^
Association details:
| Biomarker: | EGFR T858R |
|---|---|
| Cancer: | Non Small Cell Lung Cancer |
| Drug: | Tagrisso (osimertinib) (EGFR inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
The efficacy and safety of osimertinib in treating nonsmall cell lung cancer: A PRISMA-compliant systematic review and meta-analysis
Published date:
08/21/2020
Excerpt:
Patients with the T858R mutation may have a better OS than Del 19 mutation (HR = 0.55, P = .037)...
DOI:
10.1097/MD.0000000000021826
